F Beeldens
Impact in
- Hematology top 2%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Multiple Myeloma Research and Treatments
- Genetics top 10%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Hematology 10
- Acute Myeloid Leukemia Research 9
- Hematopoietic Stem Cell Transplantation 3
- Multiple Myeloma Research and Treatments 2
-
- Acute Lymphoblastic Leukemia research 4
- Co-authors
- Stefan Suciu (10 shared papers)Petra Muus (10 shared papers)Dominik Selleslag (8 shared papers)Liliana Baila (4 shared papers)Boris Labar (3 shared papers)Théo de Witte (3 shared papers)Pierre W. Wijermans (2 shared papers)Aristoteles Giagounidis (2 shared papers)
- Journals
- Blood (4 papers)Leukemia (3 papers)Leukemia Research (1 paper)Journal of Clinical Oncology (1 paper)Journal of Hepatology (1 paper)
- Partner nations
- ItalyBelgiumNetherlands
In The Last Decade
F Beeldens
11 papers receiving 633 citations
Peers
Comparison fields: 5 of 40
- Hematology 526
- Genetics 133
- Public Health, Environmental and Occupational Health 150
- Molecular Biology 297
- Oncology 84
Countries citing papers authored by F Beeldens
This map shows the geographic impact of F Beeldens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F Beeldens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F Beeldens more than expected).
Fields of papers citing papers by F Beeldens
This network shows the impact of papers produced by F Beeldens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F Beeldens. The network helps show where F Beeldens may publish in the future.
Co-authors
The 25 scholars most cited alongside F Beeldens, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 403 | |
| 2 | 2005 | 63 | |
| 3 | Sequential administration of gemtuzumab ozogamicin and conventional chemotherapy as first line therapy in elderly patients with acute myeloid leukemia: a phase II study (AML-15) of the EORTC and GIMEMA leukemia groups. | 2004 | 63 |
| 4 | 2008 | 53 | |
| 5 | 2003 | 31 | |
| 6 | 2006 | 17 | |
| 7 | 2013 | 5 | |
| 8 | 2004 | 3 | |
| 9 | 2008 | 2 | |
| 10 | Cytogenetic risk group and cytogenetic response predict outcome of patients with poor-risk mds and secondary aml treated with intensive chemotherapy and stem cell transplantation in a joint study (CRIANT) of the EORTC, EBMT, SAKK, HOVON and GIMEMA leukemia groups | 2001 | 1 |
| 11 | 2005 | 1 |
About F Beeldens
F Beeldens is a scholar working on Hematology, Public Health, Environmental and Occupational Health, Molecular Biology, Oncology and Organic Chemistry, having authored 11 papers that have together received 642 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (9 papers), Acute Lymphoblastic Leukemia research (4 papers), Hematopoietic Stem Cell Transplantation (3 papers), Cancer therapeutics and mechanisms (2 papers), Multiple Myeloma Research and Treatments (2 papers), CAR-T cell therapy research (1 paper), Lymphoma Diagnosis and Treatment (1 paper) and Hepatitis C virus research (1 paper). The work is most often cited by research in Hematology (526 citations), Genetics (133 citations), Public Health, Environmental and Occupational Health (150 citations), Molecular Biology (297 citations) and Oncology (84 citations). F Beeldens has collaborated with scholars based in Italy, Belgium and Netherlands. Frequent co-authors include Stefan Suciu, Petra Muus, Dominik Selleslag, Liliana Baila, Boris Labar, Théo de Witte, Pierre W. Wijermans, Aristoteles Giagounidis, Michael Lübbert and Helmut R. Salih. Their work appears in journals such as Blood, Leukemia, Leukemia Research, Journal of Clinical Oncology and Journal of Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.